The Australian biotechs racing toward the next billion-dollar cancer drug
There’s a revolution going on in cancer treatment with more than 1,000 clinical trials underway into CAR-T therapies promising an immune response up to 1,000 times stronger than ordinary immune cells. Chasing a market worth billions, we take a look at three Australian biotechs with their elbows out. “We take your immune cells, we engineer […]